|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.9 SEK | +5.68% |
|
+22.43% | +81.13% |
| Apr. 18 | Diamyd Medical Raises SEK57 Million in Rights Issue | MT |
| Apr. 12 | Recruitment Milestone Reaches in Diamyd® Phase 3 Trial | CI |
Diamyd Medical AB (publ) reported earnings results for the first quarter ended November 30, 2023. For the first quarter, the company reported sales was SEK 0.034 million compared to SEK 0.211 million a year ago. Revenue was SEK 0.984 million compared to SEK 0.968 million a year ago.
Net loss was SEK 32.78 million compared to SEK 32.96 million a year ago. Basic loss per share from continuing operations was SEK 0.4 compared to SEK 0.4 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +81.13% | 111M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +1.69% | 22.15B | |
| -17.37% | 21.02B | |
| -9.30% | 18.15B | |
| -41.01% | 16.74B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
DIAMYD MEDICAL AB 
